Eric P. Palmer - 13 Feb 2024 Form 4 Insider Report for Cigna Group (CI)

Role
EVP, Enterprise Strategy and President & CEO, Evernorth Health Services
Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
13 Feb 2024
Transactions value $
-$1,162,523
Form type
4
Filing time
15 Feb 2024, 17:30:08 UTC
Previous filing
13 Feb 2024
Next filing
01 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $771K +5.17K +11.34% $149.14 50.7K 13 Feb 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$2.07M -6.08K -11.99% $340.00 44.6K 13 Feb 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Options Exercise $135K +905 +2.03% $149.14 45.6K 14 Feb 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Gift $0 -200 -0.44% $0.00 45.4K 15 Feb 2024 Direct
transaction CI Common Stock, $.01 Par Value Gift $0 -312 -0.69% $0.00 45K 15 Feb 2024 Direct
transaction CI Common Stock, $.01 Par Value Gift $0 +312 +27.73% $0.00 1.44K 15 Feb 2024 By Trust
holding CI Common Stock, $.01 Par Value 245 13 Feb 2024 By 401(k) F2
holding CI Common Stock, $.01 Par Value 41.1 13 Feb 2024 By Spouse's 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -5.17K -85.1% $0.00 905 13 Feb 2024 Common Stock, $.01 Par Value 5.17K $149.14 Direct F1
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -905 -100% $0.00* 0 14 Feb 2024 Common Stock, $.01 Par Value 905 $149.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Remarks:

EVP, Enterprise Strategy and President & CEO, Evernorth Health Services